| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.0059 | 1 |